Millipore Sigma Vibrant Logo

341599 FGF-10, Human, Recombinant

FGF-10, Human, Recombinant: SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.
View Products on Sigmaaldrich.com
341599
  
Preis wird abgerufen...
Preis nicht abrufbar
Die Mindestmenge muss ein Vielfaches sein von
Maximum Quantity is
Bei Bestätigung Weitere Informationen
Sie haben () gespart
 
—
Bitte erfragen
—
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

       

      Kontakt zum Kundenservice

      Übersicht

      Replacement Information

      Key Spec Table

      Purity
      ≥97% by SDS-PAGE
      Description
      OverviewRecombinant, human fibroblast growth factor 10 (FGF-10) consisting of amino acids 137-208 and expressed in E. Coli. Mature human FGF-10, a ~20 kDa protein, contains a serine-rich region near its N-terminus sharing 93% amino acid sequence identity with mouse FGF-10 and 96% with rat FGF-10.
      Catalogue Number341599
      Brand Family Calbiochem®
      References
      ReferencesBeenken, A. and M. Mohammadi. 2009. Nat. Rev. Drug Discov. 8, 235.
      Nomura, S., et al. 2008. Br. J. Cancer 99, 305.
      Zhang, X., et al. 2006. J. Biol. Chem. 281, 15694.
      Beer, H.D., et al. 2005. Oncogene 24, 5269.
      Jaskoll, T., et al. 2005. BMC Dev. Biol. 5, 11.
      Rice, R., et al. 2004. J. Clin. Invest. 113, 1692.
      Donjacour, A.A., et al. 2003. Dev. Biol. 261, 39.
      Mailleux, A.A., et al. 2002. Development 129, 53.
      Sakaue, H., et al. 2002. Genes Dev. 16, 908.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Pirvola, U., et al. 2000. J. Neurosci. 20, 6125.
      Weaver, M., et al. 2000. Development 127, 2695.
      Igarashi, M., et al. 1998. J. Biol. Chem. 273, 13230.
      Min, H., et al. 1998. Genes Dev. 12, 3156.
      Bellusci, S., et al. 1997. Development 124, 4867.
      Emoto, H., et al. 1997. J. Biol. Chem. 272, 23191.
      Product Information
      FormLiquid
      FormulationLyophilized from 0.2 µm sterile-filtered MOPS, Na₂SO₄, EDTA, DTT, BSA.
      Quality LevelMQ100
      Applications
      Biological Information
      Biological activityED₅₀ = 20-100 ng/ml measured in a cell proliferation assay using 4MBr-5 monkey epithelial cells.
      Purity≥97% by SDS-PAGE
      Physicochemical Information
      ContaminantsEndotoxin: <1.0 EU/µg protein
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      341599 0

      Documentation

      FGF-10, Human, Recombinant SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      FGF-10, Human, Recombinant Analysenzertifikate

      TitelChargennummer
      341599

      Literatur

      Übersicht
      Beenken, A. and M. Mohammadi. 2009. Nat. Rev. Drug Discov. 8, 235.
      Nomura, S., et al. 2008. Br. J. Cancer 99, 305.
      Zhang, X., et al. 2006. J. Biol. Chem. 281, 15694.
      Beer, H.D., et al. 2005. Oncogene 24, 5269.
      Jaskoll, T., et al. 2005. BMC Dev. Biol. 5, 11.
      Rice, R., et al. 2004. J. Clin. Invest. 113, 1692.
      Donjacour, A.A., et al. 2003. Dev. Biol. 261, 39.
      Mailleux, A.A., et al. 2002. Development 129, 53.
      Sakaue, H., et al. 2002. Genes Dev. 16, 908.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Pirvola, U., et al. 2000. J. Neurosci. 20, 6125.
      Weaver, M., et al. 2000. Development 127, 2695.
      Igarashi, M., et al. 1998. J. Biol. Chem. 273, 13230.
      Min, H., et al. 1998. Genes Dev. 12, 3156.
      Bellusci, S., et al. 1997. Development 124, 4867.
      Emoto, H., et al. 1997. J. Biol. Chem. 272, 23191.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision20-Sepmtember-2011 RFH
      DescriptionRecombinant, human fibroblast growth factor 10 (FGF-10) consisting of amino acids 137-208 and expressed in E. Coli. Mature human FGF-10, a ~20 kDa protein, contains a serine-rich region near its N-terminus sharing 93% amino acid sequence identity with mouse FGF-10 and 96% with rat FGF-10.
      FormLiquid
      FormulationLyophilized from 0.2 µm sterile-filtered MOPS, Na₂SO₄, EDTA, DTT, BSA.
      Purity≥97% by SDS-PAGE
      ContaminantsEndotoxin: <1.0 EU/µg protein
      Biological activityED₅₀ = 20-100 ng/ml measured in a cell proliferation assay using 4MBr-5 monkey epithelial cells.
      SolubilityReconstitute to 100 µg/ml in sterile PBS containing at least 0.1% human or bovine serum albumin.
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesBeenken, A. and M. Mohammadi. 2009. Nat. Rev. Drug Discov. 8, 235.
      Nomura, S., et al. 2008. Br. J. Cancer 99, 305.
      Zhang, X., et al. 2006. J. Biol. Chem. 281, 15694.
      Beer, H.D., et al. 2005. Oncogene 24, 5269.
      Jaskoll, T., et al. 2005. BMC Dev. Biol. 5, 11.
      Rice, R., et al. 2004. J. Clin. Invest. 113, 1692.
      Donjacour, A.A., et al. 2003. Dev. Biol. 261, 39.
      Mailleux, A.A., et al. 2002. Development 129, 53.
      Sakaue, H., et al. 2002. Genes Dev. 16, 908.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Pirvola, U., et al. 2000. J. Neurosci. 20, 6125.
      Weaver, M., et al. 2000. Development 127, 2695.
      Igarashi, M., et al. 1998. J. Biol. Chem. 273, 13230.
      Min, H., et al. 1998. Genes Dev. 12, 3156.
      Bellusci, S., et al. 1997. Development 124, 4867.
      Emoto, H., et al. 1997. J. Biol. Chem. 272, 23191.